Author:
Boytsov S. A.,Luk’yanov M. M.,Yakushin S. S.,Martsevich S. Yu.,Vorobyov A. N.,Zagrebelny A. V.,Pereverzeva K. G.,Pravkina E. A.,Deev A. D.,Andreenko E. Yu.,Ershova A. I.,Meshkov A. N.,Myasnikov R. P.,Serdyuk S. S.,Kharlap M. S.,Bazaeva E. V.,Kozminsky A. N.,Moseychuk K. A.,Kudryashov E. N.
Abstract
Aim.To study the structure of concomitant cardiovascular and comobid pathology, risk factors in patients with arterial hypertension (AH), coronary heart disease (CHD), with congestive heart failure (CHF) and atrial fibrillation (AF), and to evaluate the quality of diagnostics and treatment in the conditions of real outpatient-polyclinic practice by the Registry in Ryazanskaya region – a RF region with high level of cardiovascular mortality.Material and methods.Into the outpatient-polyclinic registry RECVAZA (Registry of cardiovascular diseases) totally 3690 patients included with AH, CHD, with CHF, AF and their comorbidity, who admitted physicians’ offices in 3 outpatient institutions in Ryazan city: 1047 (28%) males and 2643 (72%) females, mean age 66,1±12,9 y.o.Results.The AHG diagnosis was mentioned in 3648 (98,9%) patients: CHD – in 2548 (69,1%), CHF – 2726 (73,9%), AF – 530 (14,4%). In 79,5% cases there was comorbidity. In general each one patient had 2,6 diagnoses of 4 analyzed. Myocardial infarction and brain stroke were in 11,4% and 9,5% patients’ anamnesis; diabetes – in 19,1%. The level of investigation of patients did not match the expected level with cardiologic pathology. There was non-sufficient amount of investigations and drugs prescribed, especially ACE inhibitors and angiotensine receptor blockers in CHF patients, statins in CHD, beta-blockers in patients with myocardial infarction, anticoagulants in AF, though they had indications. At the moment of Registry, a discount rate of drug price had 16,7% patinets vs. 33,1% in previous years (p<0,0001).Conclusion.RECVAZA results revealed in AH, CHD, CHF and AF patients high prevalence of cardiovascular comorbidity, non-sufficient risk factors evelauation nad accordance to national and international guidelines for treatment – important and real gap for diagnostics and treatment quality improvement in AH, CHD, CHF, AF anf their concomitance.
Subject
Cardiology and Cardiovascular Medicine
Reference15 articles.
1. WHO Global InfoBase. Available at: https://apps.who.int/infobase/Mortality.aspx. Accessed by 12.11.2014.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart Disease and Stroke Statistics -2013 Update: A Report From the American Heart Association. Circulation 2013;127: e6-245.
3. Health and demographic indicators of the Russian Federation (2012). Statistical materials. Moscow: Russian Ministry of Health; 2013. Russian (Mediko-demograficheskie pokazateli Rossiiskoi Federatsii (2012). Statisticheskie materialy. M.: Minzdrav Rossii; 2013).
4. Shal’nova SA, Deev AD. Coronary heart disease in Russia: prevalence and treatment (according to clinical and epidemiological studies). Ter Arkhiv 2012; 83(1): 7-12. Russian (Shal'nova S.A., Deev A.D. Ishemicheskaya bolezn' serdtsa v Rossii: rasprostranennost' i lechenie (po dannym kliniko-epidemiologicheskikh issledovanii). Ter arkhiv 2012; 83(1):7-12).
5. Martsevich SYu, Ginzburg ML, Kutishenko NP, et al. The LIS study (Lubertsy mortality study of patients with acute myocardial infarction): a portrait of the patient. Cardiovascular Therapy and Prevention 2011; 10(6): 89-93. Russian (Martsevich S.Yu., Ginzburg M. L., Kutishenko N. P. i dr. Issledovanie LIS (Lyuberetskoe issledovanie smertnosti bol'nykh, perenesshikh ostryi infarkt miokarda): portret zabolevshego. Kardiovaskulyarnaya terapiya i profilaktika 2011;10(6):89-93).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献